JP Patent

JP4700616B2 — 免疫抑制化合物および組成物

Assigned to IRM LLC · Expires 2011-06-15 · 15y expired

What this patent protects

Patent listed against Mayzent.

Drugs covered by this patent

Mayzent (SIPONIMOD) · Novartis

Patent Metadata

Patent number: JP4700616B2
Jurisdiction: JP
Classification: —
Expires: 2011-06-15
Drug substance claim: No
Drug product claim: No
Assignee: IRM LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.